特刊“肠道菌群失调：分子机制与疗法2.0”的社论
Editorial for the Special Issue "Gut Dysbiosis: Molecular Mechanisms and Therapies 2.0".
作者信息
Stolfi Carmine, Laudisi Federica
机构信息
Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
出版信息
Biomedicines. 2024 Sep 26;12(10):2186. doi: 10.3390/biomedicines12102186.
Abstract
Gut homeostasis depends on maintaining a fine equilibrium between the intestinal epithelial barrier, the microbiota, and the host's immune system [...].
摘要
肠道稳态取决于维持肠道上皮屏障、微生物群和宿主免疫系统之间的精细平衡[……]。
相似文献
1
Editorial for the Special Issue "Gut Dysbiosis: Molecular Mechanisms and Therapies 2.0".特刊“肠道菌群失调：分子机制与疗法2.0”的社论
Biomedicines. 2024 Sep 26;12(10):2186. doi: 10.3390/biomedicines12102186.
2
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review.肠道微生物失调引起的炎症性疾病的免疫机制：综述。
Biomed Pharmacother. 2023 Aug;164:114985. doi: 10.1016/j.biopha.2023.114985. Epub 2023 Jun 11.
3
Gut Microbiota and Immune System Interactions.肠道微生物群与免疫系统的相互作用
Microorganisms. 2020 Oct 15;8(10):1587. doi: 10.3390/microorganisms8101587.
4
Microbiota and Colorectal Cancer: From Gut to Bedside.微生物群与结直肠癌：从肠道到床边
Front Pharmacol. 2021 Sep 30;12:760280. doi: 10.3389/fphar.2021.760280. eCollection 2021.
5
Advances in Restoration for β-Lactam Antibiotic-Induced Dysbiosis: A System Review in Intestinal Microbiota and Immune Homeostasis.β-内酰胺类抗生素诱导的肠道菌群失调的恢复进展：肠道微生物群与免疫稳态的系统评价
Microorganisms. 2023 Jan 11;11(1):179. doi: 10.3390/microorganisms11010179.
6
The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice.肠道微生物群失调-癌症轴：为临床实践提供新见解和启示
Front Pharmacol. 2023 Jun 9;14:1208044. doi: 10.3389/fphar.2023.1208044. eCollection 2023.
7
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
8
Crosstalk between COVID-19 and the gut-brain axis: a gut feeling.新冠病毒与肠脑轴的相互作用：一种直觉。
Postgrad Med J. 2024 Jul 18;100(1186):539-554. doi: 10.1093/postmj/qgae030.
9
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?从肠道微生物群到胃肠胰神经内分泌肿瘤：我们是否走在通往地狱的高速公路上？
Rev Endocr Metab Disord. 2021 Sep;22(3):511-525. doi: 10.1007/s11154-020-09589-y. Epub 2020 Sep 15.
10
Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications.肠道微生物群作为慢性炎症的一个贡献者及其潜在的修饰。
Nutrients. 2021 Oct 28;13(11):3839. doi: 10.3390/nu13113839.
本文引用的文献
1
The interplay between diet and the gut microbiome: implications for health and disease.饮食与肠道微生物组的相互作用：对健康和疾病的影响。
Nat Rev Microbiol. 2024 Nov;22(11):671-686. doi: 10.1038/s41579-024-01068-4. Epub 2024 Jul 15.
2
Gut dysbiosis: Ecological causes and causative effects on human disease.肠道菌群失调：生态原因及其对人类疾病的因果影响。
Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2316579120. doi: 10.1073/pnas.2316579120. Epub 2023 Dec 4.
3
Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis.粪便微生物群移植治疗溃疡性结肠炎的疗效和安全性：系统评价和荟萃分析。
Sci Rep. 2023 Sep 3;13(1):14494. doi: 10.1038/s41598-023-41182-6.
4
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.粪便微生物群移植成功的关键决定因素：从微生物组学到临床。
Cell Host Microbe. 2023 May 10;31(5):712-733. doi: 10.1016/j.chom.2023.03.020.
5
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial.粪便微生物群移植治疗首次或第二次艰难梭菌感染（EarlyFMT）：一项随机、双盲、安慰剂对照试验。
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1083-1091. doi: 10.1016/S2468-1253(22)00276-X. Epub 2022 Sep 22.
6
Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts.饮食引发炎症性肠病：临床前和临床概念。
Gut. 2022 Dec;71(12):2574-2586. doi: 10.1136/gutjnl-2021-326575. Epub 2022 Sep 16.
7
The microbiome and gut homeostasis.微生物组与肠道内稳态。
Science. 2022 Jul;377(6601):eabp9960. doi: 10.1126/science.abp9960. Epub 2022 Jul 1.
8
Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.高级糖基化终产物（AGEs）：形成、化学、分类、受体以及与 AGEs 相关的疾病。
Cells. 2022 Apr 12;11(8):1312. doi: 10.3390/cells11081312.
9
The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes.AGE-RAGE 信号在糖尿病肠道通透性调节中的作用。
Int J Mol Sci. 2022 Feb 3;23(3):1766. doi: 10.3390/ijms23031766.
10
The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip.肠道上皮模型从细胞系到芯片上肠道的发展。
Int J Mol Sci. 2021 Dec 15;22(24):13472. doi: 10.3390/ijms222413472.
Zotero 插件